Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
- - - - - - - 8,48 M
0,51%0,58%17.72x2.32x4.09x9.62x11.23x 75,96 Md
0,65%0,67%22.79x3.55x4.95x14.39x17.77x 49,03 Md
-.--%-.--%35.94x7.39x12.28x23.37x27.35x 47,88 Md
3,15%3,23%-58.2x2.68x3.39x10.02x11.68x 43,39 Md
-.--%-.--%37.93x1.7x3.44x12.89x14.62x 30,8 Md
-.--%-.--%53.82x4.12x3.4x26.33x23.45x 24,45 Md
-.--%-.--%-6.64x4.03x9.07x-5.85x-5.46x 22,75 Md
-.--%0,05%64.19x5.58x6.07x41.78x48.25x 19,24 Md
-.--%-.--%-36.55x-6.54x17.57x-48.07x-55.04x 16,04 Md
-.--%-.--%22.86x3.36x4.93x12.83x17.83x 15,87 Md
0,15%0,15%63.49x25.89x50.48x71.4x73.63x 13,02 Md
-.--%-.--%17.98x - 3.68x14.22x16.61x 11,74 Md
-.--%-.--%-102.17x11237.82x11.04x-79.04x-109.09x 10,92 Md
-.--%-.--%43.35x - - - - 9,61 Md
2,7%2,95%12.99x1.21x1.91x7.66x10.43x 7,03 Md
0,34%0,4%30.13x - 8.14x21.59x25.78x 6,17 Md
-.--%-.--%60.21x7.23x5.86x32.4x43.64x 5,93 Md
-.--%-.--%-115.99x - - - - 5,72 Md
Moyenne 0,42% 0,45% 9,10x 807,17x 9,39x 10,35x 10,79x 21,87 Md
Moyenne pondérée par Capi. 0,55% 0,59% 12,79x 324,88x 7,70x 11,86x 13,05x
Biopharmacies